Estudo comparativo entre o gasto com o tratamento convencional e o gasto com o implante de plasma rico em plaquetas, nos pacientes com pseudartrose da tíbia, na perspectiva do Sistema Único de Saúde.

Abstract

Fractures, especially those resulting from traffic accidents, and their complications, represent an important condition that has led to increasing costs for SUS, both in primary treatment and in the care of their injuries. One of them, pseudarthrosis, a well-known entity in orthopedics, is a complication of fractures where the bone does not present consolidation characteristics. Faced with a scenario, in which the increase in hospital costs in the surgical treatment of fractures is observed, as well as pension expenses embedded in the cost of pensions and retirements, resulting in loss of work activity with great repercussion in the country's economy, we decided to carry out a clinical trial comparing the expense of conventional surgical treatment for tibial pseudoarthrosis, using plates and screws, intramedullary nail or external fixators, with the use of a new technology: the injection of platelet-rich plasma in the focus of the referred lesion, in patients treated by the Unified Health System.